Ratings by Jefferies (Michael Sarcone)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/23/2026 | Inspire Medical Systems | INSP | Maintain | Hold (N/A) |
|
Details | ||
| 1/12/2026 | Inspire Medical Systems | INSP | Maintain | Hold (N/A) |
|
Details | ||
| 12/4/2025 | AxoGen, Inc. | AXGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2025 | EDAP TMS S.A. | EDAP | Maintain | Hold (N/A) |
|
Details | ||
| 10/24/2025 | Inspire Medical Systems | INSP | Downgrade | Hold (Buy) |
81.59 (41.75) |
-48.83% | Details | |
| 10/10/2025 | DENTSPLY SIRONA | XRAY | Maintain | Hold (N/A) |
|
Details | ||
| 10/10/2025 | Align Technology | ALGN | Downgrade | Hold (Buy) |
133.09 (168.49) |
26.6% | Details | |
| 8/5/2025 | AxoGen, Inc. | AXGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2025 | Inspire Medical Systems | INSP | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2025 | EDAP TMS S.A. | EDAP | Downgrade | Hold (Buy) |
1.87 (4.32) |
131.02% | Details | |
| 3/4/2025 | Procept BioRobotics Corp | PRCT | Maintain | Hold (N/A) |
|
Details | ||
| 11/14/2024 | Procept BioRobotics Corp | PRCT | New Coverage | Hold (N/A) |
92.25 (20.60) |
-77.67% | Details | |
| 10/29/2024 | Glaukos Corporation | GKOS | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2024 | Inspire Medical Systems | INSP | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2024 | Glaukos Corporation | GKOS | Upgrade | Buy (Hold) |
105.03 (134.65) |
28.2% | Details | |
| 1/19/2024 | Inspire Medical Systems | INSP | New Coverage | Buy (N/A) |
187.66 (81.59) |
-56.52% | Details | |
| 1/8/2024 | AxoGen, Inc. | AXGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2023 | LeMaitre Vascular | LMAT | Downgrade | Hold (Buy) |
62.82 (91.95) |
46.37% | Details | |
| 4/18/2023 | EDAP TMS S.A. | EDAP | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2023 | AxoGen, Inc. | AXGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | AxoGen, Inc. | AXGN | New Coverage | Buy (N/A) |
13.09 (44.69) |
241.41% | Details | |
| 11/1/2022 | EDAP TMS S.A. | EDAP | New Coverage | Buy (N/A) |
9.18 (1.87) |
-79.63% | Details |
